MAP PHARMACEUTICALS INC (NASDAQ: MAPP)

View Portfolio
Back to Investopedia
Back to Investopedia




$15.01 -0.02 (-0.13%)
Real-time 12:00:00 AM ET
 Turn On
KEY STATS
52-Week High Price
16.80
52-Week Low Price
1.57
Avg Volume (3 Mo.)
0.00 M
Market Cap
0.37 B
P/E Ratio (TTM)
0.1
Diluted EPS (TTM)
-0.23
Shares
24.50 M
Dividend Rate ($) / (%)
0.00/0.00
85%
15%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : 22% - MAPP has underperformed the S&P 500 by 4%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
MEDICINES CO THE (MDCO) $7.51 -  $0.10(1.35%)0.40 B
QUIDEL CORP (QDEL) $12.62 -  $0.36(2.77%)0.39 B
AFFYMAX INC (AFFY) $20.45 -  $0.37(1.84%)0.39 B
FACET BIOTECH CORP (FACT) $15.71 -  $0.25(1.62%)0.39 B
PRESTIGE BRANDS HOLDINGS (PBH) $7.30 -  $0.10(1.39%)0.38 B
IMMUNOGEN INC (IMGN) $6.41 -  $0.06(0.94%)0.37 B
ZYMOGENETICS INC (ZGEN) $5.10 -  $0.02(0.39%)0.36 B
SURMODICS INC (SRDX) $19.71 -  $0.16(0.82%)0.34 B
AMERICAN ORIENTAL BIOENG (AOB) $4.10 -  $0.02(0.44%)0.33 B
LEXICON PHARMACEUTICALS (LXRX) $1.72 -  $0.00(0.29%)0.31 B
As of February 09, 2010 at 1:11 PM ET
STOCK ANALYSIS
Stock Analysis
Biotechnology Industry Hits On The Capital Markets (ISPH, ARIA, MITI, MAPP)
The Biotechnology industry is starting to raise capital again as the markets loosen up, and investors remain attrac...
View All Stock Analysis
MAPP RELATED HEADLINES
arrow
Healthcare Stock Alert for MAP Pharmaceuticals Inc. issued by Beacon Equity
Healthcare Stock Alert for MAP Pharmaceuticals Inc. issued by Beacon Equity
by GlobeNewswire 1/13/2010
arrow
Call Volume Surges on MAP Pharmaceuticals Inc.
Option traders are adding new bullish bets today on MAP Pharmaceuticals Inc. (MAPP), amid a 36% rally in the shares...(Read More)
By SchaeffersResearch 1/11/2010
arrow
Biotechnology Industry Hits On The Capital Markets (ISPH, ARIA, MITI, MAPP)
The Biotechnology industry is starting to raise capital again as the markets loosen up, and investors remain attracted to this sector due to the high return yet high risk payoff.
at Investopedia Advisor 8/12/2009
arrow
MAP Pharmaceuticals (MAPP) NewsBite - MAPP Upgraded By Leerink Swann
MAP Pharmaceuticals (MAPP) was upgraded today by analysts at Leerink Swann and the stock is now at $11.80, up $1.71 (16.95%) on volume of 604,380 shares traded. The analysts lifted the stock to Outperform from Market Perform. Over the last 52 weeks the stock has ranged from a low of $1.57 to a high of $13.85. MAP Pharmaceuticals stock has been showing support around $...
At Market Intelligence Center 6/15/2009
arrow
MAP Pharmaceuticals (MAPP) NewsBite - One Of Today's Top Losers So Far
MAP Pharmaceuticals (MAPP) leads the list of top losers so far today and is now at $12.26, down $.98 (-7.4%) on volume of 970,284 shares traded. Over the last 52 weeks the stock has ranged from a low of $1.57 to a high of $14.80. MAP Pharmaceuticals stock has been showing support around $11.34...
At Market Intelligence Center 5/29/2009
arrow
MAP Pharma says kids' asthma drug fails study

Forbes.com 2/23/2009
View All Headlines
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM2